Wiley Bros. Aintree Capital, LLC Charles River Laboratories International, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 6,003 shares of CRL stock, worth $929,864. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,003
Previous 3,295
82.19%
Holding current value
$929,864
Previous $680,000
73.82%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
51.4MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$954 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$788 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$631 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$330 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$300 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...